Michael Stahl

Pharmacokinetics and Pharmacodynamics of a Proposed Pegfilgrastim Biosimilar MSB11455 Versus the Reference Pegfilgrastim Neulasta® in Healthy Subjects: a Randomized, Double-blind Trial.

A. Schueler, P. Griffin, C. S. Yue, 2020, Clinical therapeutics.

Demonstrating biosimilar and originator antidrug antibody binding comparability in antidrug antibody assays: a practical approach.

J. Ryding, M. Ullmann, Michael Stahl, 2017, Bioanalysis.